Vestrant (Fulvestrant Vials) 250mg/5ml

Vestrant (Fulvestrant) 250mg/5ml vials are prescribed for hormone receptor-positive breast cancer treatment. This injectable estrogen receptor antagonist supports targeted therapy for metastatic conditions. Store between 2–8°C to maintain potency. Consult a healthcare provider for suitability.

Strength

250mg/5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Getwell Oncology Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vestrant (Fulvestrant) is used to treat hormone receptor-positive metastatic breast cancer in postmenopausal women. It works by blocking estrogen receptors, slowing tumor growth. This medication is often prescribed after other hormone therapies have been tried. It may also be used in combination with other treatments.

Side Effects

Vestrant may cause mild to moderate injection site reactions, such as pain or redness. Some users report fatigue, nausea, or hot flashes during treatment. These effects are typically temporary and vary by individual. Regular monitoring can help manage any discomfort.

Precautions & Warnings

Store Vestrant vials refrigerated between 2–8°C and protect from light. Avoid freezing or shaking the vial. Use within the specified timeframe after opening. Discard any unused portion as directed. Keep out of reach of children and pets.

Avoid Interactions

Vestrant may interact with medications that affect liver enzymes, such as CYP3A4 inhibitors or inducers. Caution is advised when combining with blood thinners or other hormone therapies. Alcohol use should be discussed with a healthcare provider. Always inform your doctor about all medications and supplements.

Frequently Asked Questions

Vestrant is used to treat hormone receptor-positive metastatic breast cancer in postmenopausal women.

Store Vestrant vials refrigerated between 2–8°C and protect from light.

Vestrant may interact with certain medications; consult a healthcare provider before combining treatments.

Common side effects include injection site reactions, fatigue, nausea, and hot flashes.

No, Vestrant requires a prescription and should only be used under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.